Hepatitis E virus serology and PCR: does the methodology matter?
- 787 Downloads
Hepatitis E virus (HEV) genotype 3 is an emerging pathogen in the developed world. As the clinical manifestations and routine laboratory parameters are often nonspecific, accurate diagnostic tests are crucial. In the current study, the performance of six serological assays and three PCR assays for the detection of HEV was evaluated. In the setting of the Ghent University Hospital, patients with clinically suspected HEV infection were tested for the presence of HEV IgM and IgG as well as HEV RNA. Serology was performed using six commercial HEV ELISA assays: Biorex, Wantai and Mikrogen IgM and IgG. HEV RNA was detected using one commercial assay (Altona RealStar®), and two optimized in-house real-time RT-PCR assays (according to Jothikumar et al., 2006 and Gyarmati et al., 2007). In addition, all three PCR assays were performed on 16 external quality control (EQC) samples. In a period of 39 months (January 2011-April 2014), 70 patients were enrolled. Using different ELISA assays, the prevalence of antibodies varied from 5.7% to 14.3% for HEV IgM and from 15.7% to 20.0% for IgG. All but two of the results of the PCR assays performed on clinical samples agreed. However, 10 out of 16 EQC samples results showed major discrepancies. We observed important differences in the performance of various serological and PCR assays. For this reason, results of both serological and molecular tests for HEV should be interpreted with caution.
KeywordsORF2 Antigen External Quality Control Sample
None of the authors had a personal or financial conflict of interest.
- 9.Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP (2007) The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 26(10):1429–1435. doi: 10.1111/j.1365-2036.2007.03504.x CrossRefPubMedGoogle Scholar
- 13.Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW, Toth TE, Meng XJ (2002) Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol 40(4):1326–1332CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA (2013) Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 58(4):629–634. doi: 10.1016/j.jcv.2013.10.010 CrossRefPubMedGoogle Scholar
- 22.Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KE (2013) An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. PLoS One 8(5):e62980. doi: 10.1371/journal.pone.0062980 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Baylis SA, Hanschmann KM, Blümel J, Nübling CM (2011) Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 49(4):1234–1239. doi: 10.1128/JCM.02578-10 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J (2013) Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections. J Clin Microbiol. 51(6):1913–1916. doi: 10.1128/JCM.00661-13 CrossRefPubMedPubMedCentralGoogle Scholar